Categories: ALSNewsSMA

National Action Plan of the National Action Alliance for People with Rare Diseases (NAMSE) recommends AmbulanzPartner as a telemedicine service for rare diseases

The Federal Ministry of Health (BMG), the Federal Ministry of Education and Research (BMBF) and the Alliance for Chronic Rare Diseases (ACHSE e.V.) are among those involved in the National Action Alliance for People with Rare Diseases (NAMSE).


NAMSE is intended to coordinate measures to improve the health situation of people with rare diseases and initiate actions in the field of rare diseases. After a three-year coordination process, 52 proposals for measures were developed and compiled in a National Action Plan for People with Rare Diseases. The proposed measures were published in August 2013.


The integration of telemedical applications in the outpatient care of patients with rare diseases is recommended in the National Action Plan’s information management telemedicine field of action. In the proposed measure 47, AmbulanzParter is presented as an example of best practice in existing care for the identification of suitable telemedical services for rare diseases.


AmbulanzPartner is intended to serve as an orientation for the telemedical networking of patients with rare diseases and service providers. AmbulanzPartner will support NAMSE in the implementation phase of the action plan, which is now beginning.

admin

Recent Posts

The ALS app at the international ALS symposium in San Diego

On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative…

2 months ago

Which ALS outpatient clinics use the OPM classification?

Following our last newsletter on the introduction of the OPM classification in the ALS app,…

2 months ago

Submit your e-prescription in the ALS app at your ALS pharmacy and continue to support ALS research

You can now submit your e-prescription with your health card via the ALS app at…

2 months ago

The new ALS-OPM classification is now in the ALS app.

We are pleased to introduce an important new feature in the ALS app today: The…

2 months ago

Patient survey on THC:CBD in people with ALS

The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis…

2 months ago

New medication module in the outpatient partner care portal

We are pleased to inform you that we have completely revised our medication module. With…

3 months ago